Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
AVITA Medical appoints Cary Vance as President and CEO following interim tenure; Jan Stern Reed named Board Chair
-
AVITA Medical announces TGA certification of RECELL GO in Australia for burn and acute wound treatment, advancing Spray-On Skin technology
-
AVITA Medical will report its first quarter 2026 financial results after the close of the U.S. financial markets on Thursday, May 14, 2026
-
AVITA founder Fiona Wood receives ABA Lifetime Achievement Award for pioneering burn care and developing RECELL Spray-On Skin technology
-
Cohealyx interim data show ~20-day reduction in time to graft vs benchmark, with strong investigator satisfaction and consistent performance across wounds.
-
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference on Wednesday March 4
-
AVITA Medical to host investor webinar reviewing Q4 and full-year 2025 results, with business update and live Q&A session.
-
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
-
AVITA Medical reports 2025 revenue growth, completes debt refinancing, and outlines its 2026 outlook ahead of the J.P. Morgan Healthcare Conference.
-
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Soleno Therapeutics, Inc....